Controlled substances are highly regulated and must be vigilantly monitored from the laboratory to the marketplace to prevent theft and illicit sale in the black market, a growing trend. In 2011 there were 36 cases of pharmaceutical cargo theft in the United States at an average value of more than $500,000 per incident. Abundant federal and state regulations, plus increased globalization – with its stringent import and export restrictions, permits and declarations required for controlled substances – has made compliance even more challenging. Partnering with a contract development and manufacturing organization (CDMO) experienced in supply chain management of controlled substances, from Schedule II and III through to V, can prevent costly delays, steep penalties for regulatory noncompliance, and the potential postponement of a clinical trial.
Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016 The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.
December 11, 2014 A cheese manufacturing company in Wisconsin had been using static spray balls to clean their mozzarella and provolone cooling baths and was frustrated with the slow, inefficient process.
October 28, 2014 Market research estimates performed in the last 6 months have shown that the market size for
ophthalmic medications is expected to reach more than 25 billion, by the year 2015. The ophthalmology
drugs market classification is based on the type of drugs: treatment-based drugs, over-the-counter (OTC)
drugs and ocular anesthetics.